Lawrence MG - Search Results

1

The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness.

Lose F, Lawrence MG, Srinivasan S, O'Mara T, Marquart L, Chambers S, Gardiner RA, Aitken JF, Spurdle AB, Batra J, Clements JA; Australian Prostate Cancer BioResource. Lose F, et al. Among authors: lawrence mg. Biol Chem. 2012 Apr;393(5):403-12. doi: 10.1515/hsz-2011-0268. Biol Chem. 2012. PMID: 22505522 Free article.

2

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.

Veveris-Lowe TL, Lawrence MG, Collard RL, Bui L, Herington AC, Nicol DL, Clements JA. Veveris-Lowe TL, et al. Among authors: lawrence mg. Endocr Relat Cancer. 2005 Sep;12(3):631-43. doi: 10.1677/erc.1.00958. Endocr Relat Cancer. 2005. PMID: 16172196

3

The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.

Whitbread AK, Veveris-Lowe TL, Lawrence MG, Nicol DL, Clements JA. Whitbread AK, et al. Among authors: lawrence mg. Biol Chem. 2006 Jun;387(6):707-14. doi: 10.1515/BC.2006.089. Biol Chem. 2006. PMID: 16800731 Review.

4

Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases.

Lawrence MG, Veveris-Lowe TL, Whitbread AK, Nicol DL, Clements JA. Lawrence MG, et al. Cells Tissues Organs. 2007;185(1-3):111-5. doi: 10.1159/000101311. Cells Tissues Organs. 2007. PMID: 17587816 Review.

5

Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression.

Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW. Hugo H, et al. Among authors: lawrence mg. J Cell Physiol. 2007 Nov;213(2):374-83. doi: 10.1002/jcp.21223. J Cell Physiol. 2007. PMID: 17680632 Review.

6

Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.

Lai J, Myers SA, Lawrence MG, Odorico DM, Clements JA. Lai J, et al. Among authors: lawrence mg. Mol Cancer Res. 2009 Jan;7(1):129-41. doi: 10.1158/1541-7786.MCR-08-0218. Mol Cancer Res. 2009. PMID: 19147544 Free article.

7

Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.

Lawrence MG, Lai J, Clements JA. Lawrence MG, et al. Endocr Rev. 2010 Aug;31(4):407-46. doi: 10.1210/er.2009-0034. Epub 2010 Jan 26. Endocr Rev. 2010. PMID: 20103546

8

A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells.

Lai J, Lehman ML, Dinger ME, Hendy SC, Mercer TR, Seim I, Lawrence MG, Mattick JS, Clements JA, Nelson CC. Lai J, et al. Among authors: lawrence mg. RNA. 2010 Jun;16(6):1156-66. doi: 10.1261/rna.2019810. Epub 2010 Apr 20. RNA. 2010. PMID: 20406994 Free PMC article.

9

Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells.

Lawrence MG, Margaryan NV, Loessner D, Collins A, Kerr KM, Turner M, Seftor EA, Stephens CR, Lai J; APC BioResource; Postovit LM, Clements JA, Hendrix MJ. Lawrence MG, et al. Prostate. 2011 Aug 1;71(11):1198-209. doi: 10.1002/pros.21335. Epub 2011 Jan 12. Prostate. 2011. PMID: 21656830 Free PMC article.

10

Long terminal repeats act as androgen-responsive enhancers for the PSA-kallikrein locus.

Lawrence MG, Stephens CR, Need EF, Lai J, Buchanan G, Clements JA. Lawrence MG, et al. Endocrinology. 2012 Jul;153(7):3199-210. doi: 10.1210/en.2012-1267. Epub 2012 May 17. Endocrinology. 2012. PMID: 22597536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page